Top compounds associated with response to MPZL2


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CCLE pan-cancer AAC 0.22 7e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA TW 37 GDSC1000 pan-cancer AAC -0.14 0.0003
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.16 0.0004
mRNA PD318088 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
Download CSV